Wall Street analysts predict that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce $105.83 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for U.S. Physical Therapy’s earnings. The lowest sales estimate is $102.07 million and the highest is $109.59 million. U.S. Physical Therapy posted sales of $90.86 million in the same quarter last year, which suggests a positive year over year growth rate of 16.5%. The business is expected to report its next earnings report on Wednesday, June 6th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $105.83 million for the current fiscal year, with estimates ranging from $406.92 million to $416.54 million. For the next fiscal year, analysts anticipate that the firm will report sales of $448.19 million per share, with estimates ranging from $440.26 million to $456.13 million. Zacks’ sales averages are an average based on a survey of analysts that follow U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.04). The business had revenue of $103.03 million during the quarter, compared to the consensus estimate of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%.

Several equities analysts have recently commented on USPH shares. Barrington Research downgraded shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research note on Friday, November 3rd. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research note on Saturday, August 26th. BidaskClub raised shares of U.S. Physical Therapy from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 28th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $74.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 2nd. Finally, Jefferies Group LLC set a $65.00 price objective on shares of U.S. Physical Therapy and gave the company a “hold” rating in a research note on Friday, August 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $69.00.

TRADEMARK VIOLATION NOTICE: “U.S. Physical Therapy, Inc. (USPH) Expected to Post Quarterly Sales of $105.83 Million” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/14/u-s-physical-therapy-inc-usph-expected-to-post-quarterly-sales-of-105-83-million.html.

U.S. Physical Therapy (USPH) opened at $68.50 on Tuesday. The company has a market cap of $858.03, a PE ratio of 32.95, a PEG ratio of 2.93 and a beta of 1.07. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.04 and a current ratio of 2.04. U.S. Physical Therapy has a one year low of $56.50 and a one year high of $78.00.

The business also recently declared a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 17th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 1.17%. The ex-dividend date of this dividend is Thursday, November 16th. U.S. Physical Therapy’s dividend payout ratio is currently 48.19%.

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 15,000 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $66.52, for a total value of $997,800.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Glenn Mcdowell sold 1,664 shares of the company’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $59.91, for a total transaction of $99,690.24. The disclosure for this sale can be found here. Insiders have sold 26,266 shares of company stock worth $1,703,306 in the last quarter. 3.10% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the company. Pinebridge Investments L.P. lifted its stake in shares of U.S. Physical Therapy by 1.0% in the second quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after buying an additional 17 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of U.S. Physical Therapy by 77.8% in the second quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after buying an additional 1,074 shares in the last quarter. Sei Investments Co. lifted its stake in shares of U.S. Physical Therapy by 31.8% in the second quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock worth $155,000 after buying an additional 622 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of U.S. Physical Therapy in the third quarter worth approximately $170,000. Finally, Municipal Employees Retirement System of Michigan lifted its position in U.S. Physical Therapy by 3.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $178,000 after purchasing an additional 90 shares during the period. Hedge funds and other institutional investors own 93.96% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.